As the activation of these kinases can protect glioma cells from TMZ-induced cell death [18], we hypothesized that the loss of DDR kinase activation, or a premature timing of their activation, may be the reason underlying the sensitization of glioma cells to TMZ upon HDAC inhibition. The gene discussed is HDAC9; the disease is central nervous system cancer.